Infectious Diseases (all articles)
Position Statement: Management of Patients with Liver Derangement During the COVID-19 Pandemic
24 Jun, 2020 | 03:36h | UTC
Related Commentary on Twitter
New Rapid Review – @wonglaihung et al – Management of patients with #liver derangement during the #COVID19 pandemic: an Asia-Pacific position statementhttps://t.co/opV6M73KLF#livertwitter #AsiaPacific pic.twitter.com/8sHCB6ZHGr
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) June 23, 2020
How ‘Superspreading’ Events Drive Most COVID-19 Spread
24 Jun, 2020 | 03:30h | UTCHow ‘Superspreading’ Events Drive Most COVID-19 Spread – Scientific American
“As few as 10 percent of infected people may drive a whopping 80 percent of cases, in specific types of situations”
Infographic. Graduated Return to Play Guidance Following COVID-19 Infection
24 Jun, 2020 | 03:28h | UTC
Study Commentary: Dexamethasone & COVID – A Study in Immunopathology, Evidence-based Medicine, and Ourselves
24 Jun, 2020 | 03:26h | UTC
Interactive Atlas: Inside the Coronavirus
24 Jun, 2020 | 03:32h | UTCInside the Coronavirus – Scientific American
“What scientists know about the inner workings of the pathogen that has infected the world”.
Related Commentary on Twitter
https://twitter.com/ESchattner/status/1275526658364182529
[Preprint] Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
23 Jun, 2020 | 08:47h | UTCEffect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report – medRxiv
Article press release from a few days ago: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19
Related Commentary on Twitter
Kudos to @MartinLandray and team, including all patients, practitioners, administrators, funders & researchers. Amazing study. This is the new standard about how to move quickly, thoughtfully and effectively in research. Now @medrxivpreprint. Pls comment. https://t.co/0MBY13Uxvc pic.twitter.com/fFx3166nCJ
— Harlan Krumholz (@hmkyale) June 22, 2020
Updated: IDSA Guidelines on the Treatment and Management of Patients with COVID-19
23 Jun, 2020 | 08:45h | UTC
IDSA has just released updates to its COVID-19 Treatment and Management Guidelines. New recommendations have been made on the use of #remdesivir, #hydroxychloroquine, hydroxychloroquine + #azithromycin, #convalescentplasma for treatment & #famotidine. 📄 https://t.co/H4KGct57fZ pic.twitter.com/hUuU1aYS4r
— IDSA (@IDSAInfo) June 23, 2020
A Compendium Answering 150 Questions on COVID‐19 and SARS‐CoV‐2
23 Jun, 2020 | 08:38h | UTCA compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2 – Allergy
What is the Evidence to Support the 2-meter Social Distancing Rule to Reduce COVID-19 Transmission?
23 Jun, 2020 | 08:37h | UTC
Related Commentary on Twitter
https://twitter.com/DrZeshanQureshi/status/1275035326503944193
Study: Coronavirus Antibodies Can Disappear After a Few Months
21 Jun, 2020 | 23:46h | UTCClinical and immunological assessment of asymptomatic SARS-CoV-2 infections – Nature Medicine
Commentaries: Chinese study: Antibodies in COVID-19 patients fade quickly – CIDRAP AND Coronavirus antibodies may disappear 2 to 3 months after people recover, a new study found – Business Insider AND New insights can change everything we know about coronavirus antibodies – BGR – News Beezer AND Expert reaction to study looking at the immune response of 37 asymptomatic people with confirmed SARS-CoV-2 infection – Science Media Centre AND You May Have Antibodies After Coronavirus Infection. But Not for Long – The New York Times
NIH Halts Clinical Trial of Hydroxychloroquine
21 Jun, 2020 | 23:44h | UTCNIH halts clinical trial of hydroxychloroquine – NIH News Releases
Opinion: COVID-19 Evidence is Lacking for 2 Meter Distancing
21 Jun, 2020 | 23:42h | UTCCOVID-19 Evidence is lacking for 2 meter distancing – CEBM Oxford
Related: One metre or two? The science behind social distancing – The Conversation AND Scientists report flaws in WHO-funded study on 2-metre distancing – The Guardian
Covid-19: Another Study Shows ACEI/ARB Use is Not Associated with Increased Mortality Risk
21 Jun, 2020 | 23:40h | UTCEditorial: Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19 – JAMA
SARS-CoV-2 Infection in Infants Less than 90 Days Old
21 Jun, 2020 | 23:36h | UTCSARS-CoV-2 Infection in Infants Less than 90 Days Old – Journal of Pediatrics
Commentary: Babies with COVID-19 tend to have mild illness, mostly with fever – MedicalXpress
Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
21 Jun, 2020 | 23:29h | UTC
Related Commentary on Twitter
Prevalence of Taste and Smell Dysfunction #COVID19
This survey study published @JAMANetwork of 204 patients with coronavirus disease 2019 found that taste reduction was present in 55.4% of patients, whereas smell reduction was present in 41.7% of patientshttps://t.co/aQ45uD6GAD— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 18, 2020
A Rapid Risk Analysis Tool to Prioritize Response to Infectious Disease Outbreaks
21 Jun, 2020 | 23:27h | UTC
Related Commentary on Twitter
A rapid risk analysis tool to prioritise response to infectious disease outbreaks https://t.co/3TMpQvZvRx pic.twitter.com/cYygnclbaq
— BMJ Global Health (@GlobalHealthBMJ) June 17, 2020
[Abstract Only] Randomized Trial: Systematic vs. Test-Guided Treatment for Tuberculosis in Patients with Advanced HIV
21 Jun, 2020 | 23:24h | UTCSystematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Empiric systemic tuberculosis treatment not superior to test-guided treatment for HIV patients – 2 Minute Medicine AND Empirical TB Treatment Fails in Patients with Advanced HIV – Physician’s Weekly
CDC Reports Novel Resistant Meningococcus Strain
21 Jun, 2020 | 23:18h | UTCCDC reports novel resistant meningococcus strain – CIDRAP
Association of Azithromycin Use with Cardiovascular Mortality
21 Jun, 2020 | 23:21h | UTCAssociation of Azithromycin Use With Cardiovascular Mortality – JAMA Network Open
Commentary: Azithromycin tied to higher risk of death – CIDRAP
ACP: Advice on Use of N95, Surgical, and Cloth Masks to Prevent COVID-19
19 Jun, 2020 | 09:47h | UTC
Perspective: We Need Better Masks
19 Jun, 2020 | 09:46h | UTCWe Need Better Masks – Harvard Business Review
The Other Infectious Diseases Spreading in the Shadow of the Pandemic
19 Jun, 2020 | 09:40h | UTCThe other infectious diseases spreading in the shadow of the pandemic – Vox
Related: AIDS, TB and Malaria Set to Get Deadlier Due To Coronavirus (resources on the subject) AND How Covid is making it tougher to tackle TB, AIDS, malaria and child health – The Print
Perspective: COVID-19 Is Far More Lethal Than Influenza
19 Jun, 2020 | 09:43h | UTCCOVID-19 Is Far More Lethal Than Influenza – Medium
Challenges of “Return to Work” in an Ongoing Pandemic
19 Jun, 2020 | 09:44h | UTCChallenges of “Return to Work” in an Ongoing Pandemic – New England Journal of Medicine
[Preprint] Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection
19 Jun, 2020 | 09:36h | UTCLimited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection – medRxiv
Related Commentary on Twitter
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection | pre-peer review in @medrxivpreprint colleagues from @UTSWInfDis remind us that bacterial co-infections are UNCOMMON in #Covid_19 so don’t use antibiotics! https://t.co/dpNLRZiOZn
— Carlos del Rio (@CarlosdelRio7) June 18, 2020